156 related articles for article (PubMed ID: 6770270)
1. Estrogen use in postmenopausal women--costs, risks, and benefits.
Weinstein MC
N Engl J Med; 1980 Aug; 303(6):308-16. PubMed ID: 6770270
[TBL] [Abstract][Full Text] [Related]
2. Risks and benefits of long-term treatment with estrogens.
Mack TM; Ross RK
Schweiz Med Wochenschr; 1989 Dec; 119(50):1811-20. PubMed ID: 2692147
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of strategies to evaluate postmenopausal bleeding.
Feldman S; Berkowitz RS; Tosteson AN
Obstet Gynecol; 1993 Jun; 81(6):968-75. PubMed ID: 8497365
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.
Lekander I; Borgström F; Ström O; Zethraeus N; Kanis JA
Bone; 2008 Feb; 42(2):294-306. PubMed ID: 18053789
[TBL] [Abstract][Full Text] [Related]
5. Menopausal endocrinology and management.
Korenman SG
Arch Intern Med; 1982 Jun; 142(6):1131-6. PubMed ID: 7046670
[TBL] [Abstract][Full Text] [Related]
6. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
Cramer DW; Knapp RC
Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
[TBL] [Abstract][Full Text] [Related]
7. Estimated gains in life expectancy with use of postmenopausal estrogen therapy: a decision analysis.
Zubialde JP; Lawler F; Clemenson N
J Fam Pract; 1993 Mar; 36(3):271-80. PubMed ID: 8454973
[TBL] [Abstract][Full Text] [Related]
8. The adverse effects of hormonal therapy.
Bush TL
Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
[TBL] [Abstract][Full Text] [Related]
9. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.
Weiss NS; Ure CL; Ballard JH; Williams AR; Daling JR
N Engl J Med; 1980 Nov; 303(21):1195-8. PubMed ID: 7421945
[TBL] [Abstract][Full Text] [Related]
10. Alternative analytic methods for case-control studies of estrogens and endometrial cancer.
Horwitz RI; Feinstein AR
N Engl J Med; 1978 Nov; 299(20):1089-94. PubMed ID: 703785
[TBL] [Abstract][Full Text] [Related]
11. Estrogens for the menopause. Maximizing benefits, minimizing risks.
Seller JC
Postgrad Med; 1977 Sep; 62(3):73-9. PubMed ID: 197509
[TBL] [Abstract][Full Text] [Related]
12. [Risks, benefits and costs of hormone replacement therapy in menopause].
Gaspard U
Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
[TBL] [Abstract][Full Text] [Related]
13. Estrogen therapy during menopause.
Horwitz DL
Compr Ther; 1980 Mar; 6(3):3-4. PubMed ID: 7363581
[TBL] [Abstract][Full Text] [Related]
14. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
Berger GS; Fowler WC
J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
[TBL] [Abstract][Full Text] [Related]
15. Estrogen prescribing practices scrutinized at NIH conference.
Eichelberger BM
Am J Hosp Pharm; 1979 Dec; 36(12):1728. PubMed ID: 525651
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal carcinoma as a result of estrogen treatment: survey of evidence.
Mack TM
Pediatrics; 1978 Dec; 62(6 Pt 2):1104-13. PubMed ID: 724347
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
Davis SR; Dinatale I; Rivera-Woll L; Davison S
J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
[TBL] [Abstract][Full Text] [Related]
18. Cancer and the use of estrogens.
Gambrell RD
Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
[TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of hormone replacement therapy in the menopause.
Cheung AP; Wren BG
Med J Aust; 1992 Mar; 156(5):312-6. PubMed ID: 1588862
[TBL] [Abstract][Full Text] [Related]
20. Elective hysterectomy. Benefits, risks, and costs.
Sandberg SI; Barnes BA; Weinstein MC; Braun P
Med Care; 1985 Sep; 23(9):1067-85. PubMed ID: 3928987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
